NM_002661.5:c.1558-18C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002661.5(PLCG2):c.1558-18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00259 in 1,609,916 control chromosomes in the GnomAD database, including 99 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 55 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 44 hom. )
Consequence
PLCG2
NM_002661.5 intron
NM_002661.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.326
Publications
1 publications found
Genes affected
PLCG2 (HGNC:9066): (phospholipase C gamma 2) The protein encoded by this gene is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor. IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3. [provided by RefSeq, Mar 2014]
PLCG2 Gene-Disease associations (from GenCC):
- autoinflammation-PLCG2-associated antibody deficiency-immune dysregulationInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
- familial cold autoinflammatory syndrome 3Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-81908398-C-T is Benign according to our data. Variant chr16-81908398-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445753.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0134 (2038/152250) while in subpopulation AFR AF = 0.046 (1913/41542). AF 95% confidence interval is 0.0443. There are 55 homozygotes in GnomAd4. There are 969 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2038 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PLCG2 | NM_002661.5 | c.1558-18C>T | intron_variant | Intron 16 of 32 | ENST00000564138.6 | NP_002652.2 | ||
| PLCG2 | NM_001425749.1 | c.1558-18C>T | intron_variant | Intron 17 of 33 | NP_001412678.1 | |||
| PLCG2 | NM_001425750.1 | c.1558-18C>T | intron_variant | Intron 16 of 32 | NP_001412679.1 | |||
| PLCG2 | NM_001425751.1 | c.1558-18C>T | intron_variant | Intron 17 of 33 | NP_001412680.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0134 AC: 2032AN: 152132Hom.: 55 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2032
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00329 AC: 811AN: 246390 AF XY: 0.00239 show subpopulations
GnomAD2 exomes
AF:
AC:
811
AN:
246390
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00146 AC: 2133AN: 1457666Hom.: 44 Cov.: 30 AF XY: 0.00126 AC XY: 913AN XY: 724970 show subpopulations
GnomAD4 exome
AF:
AC:
2133
AN:
1457666
Hom.:
Cov.:
30
AF XY:
AC XY:
913
AN XY:
724970
show subpopulations
African (AFR)
AF:
AC:
1691
AN:
33398
American (AMR)
AF:
AC:
132
AN:
44498
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25886
East Asian (EAS)
AF:
AC:
0
AN:
39614
South Asian (SAS)
AF:
AC:
20
AN:
85666
European-Finnish (FIN)
AF:
AC:
1
AN:
53258
Middle Eastern (MID)
AF:
AC:
15
AN:
5736
European-Non Finnish (NFE)
AF:
AC:
57
AN:
1109374
Other (OTH)
AF:
AC:
217
AN:
60236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
85
170
254
339
424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0134 AC: 2038AN: 152250Hom.: 55 Cov.: 32 AF XY: 0.0130 AC XY: 969AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
2038
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
969
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
1913
AN:
41542
American (AMR)
AF:
AC:
92
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
3
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9
AN:
68016
Other (OTH)
AF:
AC:
20
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
98
196
294
392
490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jun 06, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial cold autoinflammatory syndrome 3;C3553961:Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation Benign:1
Aug 31, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial cold autoinflammatory syndrome 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.